Find and Join

• Let’s talk about that Lilly announcement

  There’s been plenty of coverage of Eli Lilly’s announcement this week that it will sell vials of Zepbound directly to consumers at a discount. But the company seems to have left out a few important caveats. read more →

• Our response to the op-ed in The Hill

  The Hill published an editorial by Dr. Kenneth McCall titled “Fake, unsafe weight-loss drugs are a worsening public health dilemma” in which he makes unfounded claims about pharmacy compounding. Here’s the response from our CEO. read more →

• The shortage ends … then what? (Find out at CCH) 

  We’ve added a new session to the Compounders on Capitol Hill lineup. Don’t miss the discussion of what’s on many a compounder’s (and regulators’ … and reporters’...) mind. read more →

• A new bronze corporate patron

  A big welcome to Ro, APC’s newest tier-level corporate patron! read more →

• Education (and CE) from USP

  For the fourth year in a row, USP will be holding a hybrid live/virtual workshop dedicated to improving the quality of compounding. read more →

• Compounding post-Chevron

  At least three issues affecting pharmacy compounding might be affected by the overturning of the decades-old “Chevron doctrine.” read more →

• 503B sourcing: our state-by-state analysis

  Do you work for one of APC’s PFMs? If you’re with a Pharmacy/Facility Member, you’ve got access to a new resource. read more →

• What we’ll be talking about at CCH

  When we get together on Capitol Hill to meet with legislators and their staffs, as much as we’d like to talk about a half-dozen issues (easily!), we’re going to be focusing on the three most important.  read more →

More News

No doubt we’re all aware of the Covid-19 pandemic and resulting shortages of medical supplies — and that includes some medications. But did you know that compounding pharmacies fill a critical gap when there are manufacturing shortages or supply chain interruptions?

One of the drugs in shortage now is hydroxychloroquine (HCQ), because of the belief that it might help treat Covid-19. But that puts patients who require HCQ for other conditions at risk. Compounding pharmacists are helping. After all, they specialize in making custom doses when normally commercially available products are on backorder, so patients are able to continue their treatment without interruption.

Also in shortage is alcohol-based hand sanitizer. Due to these unprecedented circumstances, the FDA is allowing compounding pharmacies to make their own. Compounders across the country have stepped up and have been answering that call; through a campaign called #CompoundingHandoff, many are donating hand sanitizers to police and first responders who are in desperate need.

Should you have trouble finding your commercially made medications, hand sanitizer, or immune boosting vitamin supplements, please consider contacting a compounding pharmacist near you. They’re happy to help you with your health concerns, especially during this difficult time.

Connect with P3 on social media! Please “like” or “follow” our pages and we will provide updates about compounding can help you and your family, and how to advocate to protect your access to customized medications.